Beta-blockers and lipid metabolism.
作者信息
Waal-Manning H J, Simpson F O
出版信息
Br Med J. 1977 Sep 10;2(6088):705. doi: 10.1136/bmj.2.6088.705.
Abstract
摘要
相似文献
1
Beta-blockers and lipid metabolism.β受体阻滞剂与脂质代谢
Br Med J. 1977 Sep 10;2(6088):705. doi: 10.1136/bmj.2.6088.705.
2
3
After myocardial infarction carvedilol improves insulin resistance compared to metoprolol.心肌梗死后，与美托洛尔相比，卡维地洛可改善胰岛素抵抗。
Clin Res Cardiol. 2006 Feb;95(2):99-104. doi: 10.1007/s00392-006-0336-4. Epub 2006 Feb 6.
4
Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.卡维地洛与美托洛尔对糖尿病高血压患者血脂浓度的影响比较。
Diabetes Obes Metab. 2009 Mar;11(3):234-8. doi: 10.1111/j.1463-1326.2008.00927.x. Epub 2008 Jun 17.
5
6
Beta-blockers in chronic heart failure.慢性心力衰竭中的β受体阻滞剂
Eur Heart J. 2002 Mar;23(5):426; author reply 426-7. doi: 10.1053/euhj.2001.3015.
7
Successful treatment of supraventricular tachycardia with metoprolol, a cardioselective beta blocker.使用美托洛尔（一种心脏选择性β受体阻滞剂）成功治疗室上性心动过速。
Clin Pediatr (Phila). 1983 Jul;22(7):522-3. doi: 10.1177/000992288302200714.
8
[The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].[COMET研究比较了两种不同β受体阻滞剂对慢性心力衰竭的疗效。卡维地洛优于美托洛尔]
Lakartidningen. 2003 Sep 11;100(37):2852-4.
9
[Beta-blockers for tocolysis--comparative study of celiprolol and metoprolol].[用于安胎的β受体阻滞剂——塞利洛尔与美托洛尔的对比研究]
Z Geburtshilfe Perinatol. 1987 Sep-Oct;191(5):193-8.
10
Commentary on the Carvedilol or Metoprolol European Trial (COMET).卡维地洛或美托洛尔欧洲试验（COMET）评论
Am J Cardiol. 2004 May 6;93(9A):40B-2B. doi: 10.1016/j.amjcard.2004.01.005.
引用本文的文献
1
Serum lipoprotein changes during atenolol treatment of essential hypertension.阿替洛尔治疗原发性高血压期间的血清脂蛋白变化
Eur J Clin Pharmacol. 1981;20(5):335-8. doi: 10.1007/BF00615401.
2
Oxprenolol, methyldopa and lipids in diabetes mellitus.糖尿病患者中的氧烯洛尔、甲基多巴与脂质
Br J Clin Pharmacol. 1982 Feb;13(2):219-22. doi: 10.1111/j.1365-2125.1982.tb01360.x.
3
Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.阿替洛尔与安慰剂治疗轻度高血压：肾脏代谢及应激抗高血压作用
Br J Clin Pharmacol. 1980 Jun;9(6):553-60. doi: 10.1111/j.1365-2125.1980.tb01080.x.
4
[Antihypertensive therapy and lipid metabolism].[抗高血压治疗与脂质代谢]
Klin Wochenschr. 1984 Mar 1;62(5):193-202. doi: 10.1007/BF01721044.
5
[The influence of beta-receptor blockers on metabolism (author's transl)].β受体阻滞剂对代谢的影响（作者译）
Klin Wochenschr. 1981 Jan 15;59(2):49-57. doi: 10.1007/BF01477283.
6
The effects of treatment on target organ damage in hypertensive disease.治疗对高血压疾病靶器官损害的影响。
Postgrad Med J. 1985 Sep;61(719):773-8. doi: 10.1136/pgmj.61.719.773.
7
The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.抗高血压药物对血脂和脂蛋白的影响。II. 非利尿药物。
Drugs. 1986 Oct;32(4):335-57. doi: 10.2165/00003495-198632040-00003.
8
The choice of antihypertensive therapy in the diabetic patient.糖尿病患者抗高血压治疗的选择。
Postgrad Med J. 1985 Jul;61(717):563-9. doi: 10.1136/pgmj.61.717.563.
9
Do antihypertensive drugs precipitate diabetes in predisposed men?抗高血压药物会使易感男性患糖尿病吗？
BMJ. 1989 Apr 29;298(6681):1147-52. doi: 10.1136/bmj.298.6681.1147.
本文引用的文献
1
Metabolic effects of beta-adrenoreceptor blockers.β-肾上腺素能受体阻滞剂的代谢效应
Drugs. 1976;11 SUPPL 1:121-6. doi: 10.2165/00003495-197600111-00027.
Zotero 插件